Cargando…

Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy

Inflammation and pain are two prevalent findings after ocular surgery. Corticosteroids are widely administrated as a core treatment to control post-surgical inflammation and pain. Improper patient adherence to post-operative eye drop regimens, limited bioavailability of topical eye drops, and the ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Cassandra C, Jabbehdari, Sayena, Gupta, Preeya K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968807/ https://www.ncbi.nlm.nih.gov/pubmed/32021072 http://dx.doi.org/10.2147/OPTH.S238756

Ejemplares similares

Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative survey
por: Gira, Joseph P, et al.
Publicado: (2017)

Prospective, Randomized, Fellow Eye-Controlled Study of Postoperative Pain and Inflammation Control with an Intracanalicular Dexamethasone 0.4 mg Ophthalmic Insert Following Small Incision Lenticule Extraction
por: Jee, Kathleen J, et al.
Publicado: (2022)

A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE)
por: Larsen, Jacob, et al.
Publicado: (2021)

In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study
por: Ibach, Mitchel J, et al.
Publicado: (2022)

Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation
por: Lee, Arnold, et al.
Publicado: (2020)

Retrospective Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation After Cataract and Corneal Surgery
por: Fram, Nicole, et al.
Publicado: (2022)

Correction to: Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation
por: Lee, Arnold, et al.
Publicado: (2020)

Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
por: Matossian, Cynthia, et al.
Publicado: (2022)

Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy
por: Suñer, Ivan J, et al.
Publicado: (2021)

Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults
por: Blizzard, Charles, et al.
Publicado: (2021)

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye
por: Hovanesian, John A, et al.
Publicado: (2022)

Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma
por: Jackson, Kevin J., et al.
Publicado: (2022)

Thermal Pulsation with or without Dexamethasone Intracanalicular Insert for Meibomian Gland Dysfunction: A Prospective, Masked Trial
por: Dierker, Damon S, et al.
Publicado: (2022)

Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation
por: Schopf, Lisa, et al.
Publicado: (2014)

Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis
por: Foster, Brian
Publicado: (2021)

Intracanalicular Osteochondroma in the Lumbar Spine
por: Shigekiyo, Shota, et al.
Publicado: (2019)

Intracanalicular meningioma: diagnostic by immunohistochemistry
por: Borin, Andrei, et al.
Publicado: (2015)

Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
por: Xu, Jianjiang, et al.
Publicado: (2015)

Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
por: Singh, Vinod, et al.
Publicado: (2011)

In vivo observation of intracanalicular changes in association with blinking
por: Singh, Swati, et al.
Publicado: (2018)

Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery
por: Saenz, Bobby, et al.
Publicado: (2021)

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
por: Venkateswaran, Nandini, et al.
Publicado: (2022)

Middle Fossa Approach for Resection of an Intracanalicular Vestibular Schwannoma
por: Jean, Walter C., et al.
Publicado: (2019)

Influence of Solution Treatment Time on Precipitation Behavior and Mechanical Properties of Mg-2.0Nd-2.0Sm-0.4Zn-0.4Zr Alloy
por: Ma, Tao, et al.
Publicado: (2021)

A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK)
por: Greenwood, Michael D, et al.
Publicado: (2020)

Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
por: Bortolus, Renata, et al.
Publicado: (2021)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
por: Glockler, Antonia, et al.
Publicado: (2020)

Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
por: Kowal, Tia J., et al.
Publicado: (2021)

Sealed Unilateral Full-Thickness Macular Hole with Amniotic Membrane Graft in a Patient with Alport Syndrome: A Case Report
por: Jabbehdari, Sayena, et al.
Publicado: (2023)

Self-Healing Thermosensitive Hydrogel for Sustained Release of Dexamethasone for Ocular Therapy
por: Annala, Ada, et al.
Publicado: (2022)

A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery
por: Donnenfeld, Eric D, et al.
Publicado: (2023)

Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
por: Lelescu, Cristina A., et al.
Publicado: (2020)

Ophthalmologic Findings in Patients with Neuro-metabolic Disorders
por: Jafari, Narjes, et al.
Publicado: (2018)

A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion
por: Jabbehdari, Sayena, et al.
Publicado: (2022)

Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations
por: Khurana, Gaurav, et al.
Publicado: (2012)

An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy
por: Fung, Derrick S, et al.
Publicado: (2014)

Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes
por: Colin, Joseph
Publicado: (2007)

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections
por: Kanda, Yoshiko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dntddm6p2dkq931032b5npgc86